Non-Therapeutic Biomolecules Market 2024 - By Size, Share, Trends, Growth Analysis And Outlook By 2033
Overview and Scope
Non-therapeutic biomolecule refers
to the organic compounds created by cells and living things. These compounds
come in a wide range of shapes and sizes and carry out a wide variety of tasks
in body functioning.
Sizing and Forecast
The non-therapeutic biomolecules
market size has grown rapidly in recent years. It will grow from $27.91 billion
in 2023 to $31.11 billion in 2024 at a compound annual growth rate (CAGR) of
11.4%. The growth in the historic period can be
attributed to increased research and development (r&d) investments, growing
applications in research and diagnostics, rising awareness and adoption,
strategic collaborations and partnerships, regulatory support.
The non-therapeutic biomolecules
market size is expected to see rapid growth in the next few years. It will grow
to $47.21 billion in 2028 at a compound annual growth rate (CAGR) of
11.0%. The growth in the forecast period
can be attributed to emerging market opportunities, advancements in data
analytics and integration, growing focus on precision medicine, increasing
investment in personalized healthcare, expanding application areas. Major
trends in the forecast period include technological advancements, strategic
collaborations, rising applications in agriculture, expanding role in
industrial processes, customization and personalization.
To access more details
regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
Segmentation & Regional
Insights
The non-therapeutic biomolecules
market covered in this report is segmented –
1) By Trad Pharma: Enzymes,
Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal
Antibodies
2) By End User: Research,
Pharma, In vitro diagnostics(IVD)
Top Major Players
ABB Ltd.
Schneider Electric SE
Eaton Corporation PLC
Larsen & Toubro Ltd.
Siemens AG
Asia-Pacific was the largest
region in the non-therapeutic biomolecules market share in 2023. The regions
covered in the non-therapeutic biomolecules market report are Asia-Pacific,
Western Europe, Eastern Europe, North America, South America, Middle East,
Africa.
Intrigued to explore the
contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
Major Driver Impacting Market
Growth
The rapidly increasing number of
research and laboratory testing is expected to propel the growth of the
non-therapeutic biomolecules market going forward. Laboratory testing refers to
the medical procedure that involves testing a sample of blood, urine, or other
substance from the body to determine and monitoring of disease and draft a
treatment plan, whereas research refers to the new knowledge is created or
current knowledge is creatively applied to produce new concepts, theories, and
understandings. Non-therapeutic biomolecules in laboratory testing are used to
measure the presence or concentration of a biomarker molecule that indicates
disease, to enhance the sensitivity and specificity of the test. For instance,
according to the American Association for Clinical Chemistry (AACC), a US-based
scientific and medical professional organization, more than 200,000
laboratories certified under the Clinical Laboratory Improvement Amendment
(CLIA) execute almost 13 billion laboratory tests in the US each year, and
laboratory services comprise 2.3% of U.S. healthcare expenditures and two
percent of Medicare expenditures. Therefore, the rapidly increasing number of
research and laboratory testing is driving the growth of the non-therapeutic
biomolecules market.
Key Industry Players
Major companies operating in the
non-therapeutic biomolecules market report are ABB Ltd., Schneider Electric SE,
Eaton Corporation plc, Larsen & Toubro Ltd., Siemens AG, LS Electric Co.
Ltd, Entec Electric & Electronic Co. Ltd, EPE Switchgear (M) Sdn. Bhd, Lucy
Electric Ltd., Ormazabal Corporación Empresarial S.L., Crompton Greaves
Consumer Electricals Limited, Orecco Electric d.o.o, Alfanar Group Ltd., LSIS
Co.Ltd., Toshiba Corp., CG Power & Industrial Solutions Ltd., SwitchGear
Company NV, NOJA Power Switchgear Pty Ltd., G&W Electric Company, C&S
Electric Limited, E+I Engineering Ltd., Hawker Siddeley Switchgear Ltd., Kappa
Engineering (Pty) Ltd., KONČAR - Electrical Industry Inc., Laxmi Electronics
Pvt. Ltd., MGC Moser-Glaser AG, Mors Smitt B.V, Nissin Electric Co. Ltd., RPS
Switchgear Limited, S&S Power Switchgear Limited, Slaters Electricals Ltd.,
Switchgear Power Systems LLC, Tavrida Electric AG, TE Connectivity Ltd., TGOOD
Global Ltd., Trayer Engineering Corporation, VEO Oy, Wahah Electric Supply
Company of Saudi Arabia Co., Xiamen Huadian Switchgear Co. Ltd.
The non-therapeutic
biomolecules market report table of contents includes:
1. Executive Summary
2. Non-Therapeutic Biomolecules
Market Characteristics
3. Non-Therapeutic Biomolecules
Market Trends And Strategies
4. Non-Therapeutic Biomolecules
Market - Macro Economic Scenario
5. Global Non-Therapeutic
Biomolecules Market Size and Growth
............................
31. Global Non-Therapeutic
Biomolecules Market Competitive Benchmarking
32. Global Non-Therapeutic
Biomolecules Market Competitive Dashboard
33. Key Mergers And Acquisitions
In The Non-Therapeutic Biomolecules Market
34. Non-Therapeutic Biomolecules
Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment